Histopathology in Prognosis & Therapy of Lymphocytic Lymphomas 255 



31. Jackson, H., and Parker, F., Jr. Hodgkin's Disease and Allied Disorders. 

 New York, Oxford University Press, 1947. 



32. Janssen, \\\, and Wust, G. Zur Frage Hodgkin-Sarkom odcr Retothel- 

 sarkom. Virchows Arch. path. A mil. ?2P:453-465, 1956. 



33. Jellife, A., and Thomson, A. D. The prognosis in Hodgkin's disease. Brit. 

 J. Cancer 9:21-56, 1955. 



34. Krakoff, I. H.. Karnofsky, 1).. and Burchenal, J. Remissions induced In 

 chlorambucil in chronic granulocytic leukemia. J.A.M.A. 166:629-651, 1958. 



35. Loew, M. liber den Prognose der Lymphogranulomatose. Deutsches Arch, 

 klin. Med. 202:100-725, 1956. 



36. Loew, M., and Lennert, K. 1st die klinische Unterscheidung eines Lympho- 

 granuloms und eines Paragranuloms moglich. Deutsche med. Wchnschr. 80: 

 404-406, 1955. 



37. Limb, G. Tumors of Lymphoid Tissue. Edinburgh and London. E. S. 

 Livingstone, Ltd., 1954. 



38. Marshall, A. H. E. An Outline of the Cytology and Pathology of the 

 Reticular Tissue. Springfield, 111., Charles C Thomas, Publisher, 1956. 



39. McGavron, C. W. Lymphatic leukemia of twenty-five years duration. Ann. 

 Int. Med. 72:396-402, 1938. 



40. Minot, G. B., and Isaacs, R. Lymphatic leukemia: age, duration and benefit 

 derived from irradiation. Boston Med. Surg. J. 191:1-9, 1924. 



41. Norcross, J. \\\, Cvr. D. P.. and Smedal, M. I. Some problems relating to 

 malignant lymphomas. Postgrad. Med. 27:508-519, 1957. 



42. Osgood, E., and Seaman, A. Treatment of chronic leukemias. Results of 

 therapy by filtrated, regularly spaced total body radioactive phosphorus or 

 roentgen irradiation. J.A.M.A. 150:1572-1579, 1952. 



43. Pettet, J. D., Pease, G., and Cooper, T. An evaluation of paraffin sections 

 of aspirated bone marrow in malignant lymphomas. Blood 70:820-830, 1955. 



44. PiscioTTA, A., and Hirschboek, J. Therapeutic considerations in chronic 

 lymphatic leukemia with special reference to the natural course of the disease. 

 A.M. A. Arch. Int. Med. 9P:334-345, 1957. 



45. Rappaport, PL, Winter, W., and Hicks, E. Follicular lymphoma. A re- 

 evaluation of its position in the scheme of malignant lymphoma, based on a 

 survey of 253 cases. Cancer 9:792-821, 1956. 



46. RePass, P. Long survival in chronic lymphatic leukemia. Rocky Mountain 

 M. J. 56.64-66, 1959. 



47. Ross, J., and Ebaugh, F. Current trends in the management of the leukemias 

 and lymphomas. Med. Clin. North Am. 55:1381-1401, 1957. 



48. Shimkin, M., Opperman, K., Low-Beer, B., and Mettier, S. Lymphosaroma: 

 an analysis of frequency, distribution and mortality at The University of Cali- 

 fornia Hospital 1913-1948. Ann. Int. Med. 40:1095-1107, 1954. 



49. Smetana, H., and Cohen, B. Mortality in relation to histologic type in 

 Hodgkin's disease. Blood 77:211-224, 1956. 



50. Steiner, P. E. Hodgkin's disease: incidence, distribution, nature and possible 

 significance of lymphogranulomatous lesions in bone marrow; a review with 

 original data. Arch. Path. 36:627-657, 1943. 



51. Sternberg, S., Phillips, F.. and Scholler, J. Pharmacological and patho- 

 logical effects of alkylating agents. Ann. New York Acad. Sc. 6#:8 11-825, 1958. 



52. Sykes, M. P., Phillips, F. J., and Karnofsky, D. Comparative therapeutic 



